ask="2.49"
ask_size="2000"
average_daily_volume="62155"
bid="2.25"
bid_size="5000"
book_value="1.40"
change="-1.25"
change_from_200_day_moving_average="1.41"
change_from_50_day_moving_average="1.33"
change_from_52_week_high="-2.37"
change_From_52_week_low="1.82"
change_in_percent="-34.92%"
close="2.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="1824000"
high="2.50"
high_52_weeks="4.70"
last_trade_date="2/17/2017"
last_trade_price="2.33"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.13"
low_52_weeks="0.51"
market_capitalization="6.24M"
moving_average_200_day="0.92"
moving_average_50_day="1.00"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+152.45%"
percent_change_from_50_day_moving_average="+134.10%"
percent_change_from_52_week_high="-50.43%"
percent_change_from_52_week_low="+356.86%"
previous_close="3.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.12"
stock_exchange="NCM"
symbol="XTLB"
volume="1326496"
weeks_range_52="0.51 - 4.70"
